Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.
Dattola A, Bernardini N, Anedda J, Atzori L, Bonifati C, Bruni PL, Graceffa D, Giordano D, Molinelli E, Moretta G, Mugheddu C, Offidani A, Pagnanelli G, Pallotta S, Papini M, Persechino S, Richetta AG, Tolino E, Pellacani G, Potenza C. Dattola A, et al. Among authors: pallotta s. Ital J Dermatol Venerol. 2024 Aug;159(4):467-469. doi: 10.23736/S2784-8671.24.07921-0. Epub 2024 Jun 3. Ital J Dermatol Venerol. 2024. PMID: 38829271 No abstract available.
Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms.
Cappello A, Mancini M, Madonna S, Rinaldo S, Paone A, Scarponi C, Belardo A, Zolla L, Zuccotti A, Panatta E, Pallotta S, Annicchiarico-Petruzzelli M, Albanesi C, Cutruzzolà F, Wang L, Jia W, Melino G, Candi E. Cappello A, et al. Among authors: pallotta s. Sci Adv. 2022 Dec 16;8(50):eabm7902. doi: 10.1126/sciadv.abm7902. Epub 2022 Dec 16. Sci Adv. 2022. PMID: 36525488 Free article.
The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.
Madonna S, Scarponi C, Sestito R, Pallotta S, Cavani A, Albanesi C. Madonna S, et al. Among authors: pallotta s. J Immunol. 2010 Aug 15;185(4):2467-81. doi: 10.4049/jimmunol.1001426. Epub 2010 Jul 19. J Immunol. 2010. PMID: 20644166
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
Morelli M, Scarponi C, Mercurio L, Facchiano F, Pallotta S, Madonna S, Girolomoni G, Albanesi C. Morelli M, et al. Among authors: pallotta s. J Immunol Res. 2018 Nov 19;2018:7897263. doi: 10.1155/2018/7897263. eCollection 2018. J Immunol Res. 2018. PMID: 30581877 Free PMC article.
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study.
Salemme A, Fania L, Scarabello A, Caproni M, Marzano AV, Cozzani E, Feliciani C, De Simone C, Papini M, Satta RR, Parodi A, Mariotti F, Lechiancole S, Genovese G, Passarelli F, Festa F, Bellei B, Provini A, Sordi D, Pallotta S, Abeni D, Mazzanti C, Didona B, Di Zenzo G; Cutaneous Immunology Group of SIDeMaST. Salemme A, et al. Among authors: pallotta s. J Am Acad Dermatol. 2022 Jul;87(1):56-63. doi: 10.1016/j.jaad.2022.02.036. Epub 2022 Mar 1. J Am Acad Dermatol. 2022. PMID: 35240229
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study.
Caldarola G, Galluzzo M, Bernardini N, Calabrese L, Grimaldi M, Moretta G, Pagnanelli G, Shumak RG, Talamonti M, Tofani L, Pallotta S, Peris K, Potenza C, De Simone C, Campione E. Caldarola G, et al. Among authors: pallotta s. Dermatol Ther. 2022 Jun;35(6):e15488. doi: 10.1111/dth.15488. Epub 2022 Apr 11. Dermatol Ther. 2022. PMID: 35384168 Free PMC article.
165 results